83
Growth Score in past quarter
pts
Heat Score 83 in past quarter
5 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
278223
Immudex develops and commercializes products for the quantitation, characterization, and generation.
- Helene Kähler Hjenner: Chief Executive Officer
- Helene Kähler Hjenner: Chief Executive Officer
About the Company
Immudex is a pioneering life science company spearheading the global adoption of precision immune monitoring. Since 2009, Immudex strives to provide researchers worldwide with reliable tools to monitor the cellular immune response accurately. Immudex markets prime Dextramer® and dCODE® (DNA-barcoded) MHC multimer technologies that grant researchers
and clinicians detailed insights into disease-specific immunity resolved to antigen-specific cell populations and single cells.